These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 21649506

  • 1. Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control.
    Lee IH, Park JB, Cheong M, Choi YS, Park D, Sin JI.
    DNA Cell Biol; 2011 Dec; 30(12):975-85. PubMed ID: 21649506
    [Abstract] [Full Text] [Related]

  • 2. MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model.
    Sin JI.
    Vaccine; 2011 May 31; 29(24):4125-31. PubMed ID: 21496466
    [Abstract] [Full Text] [Related]

  • 3. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH, Jin HT, Park SH, Youn JI, Sung YC.
    Vaccine; 2009 Sep 25; 27(42):5906-12. PubMed ID: 19651174
    [Abstract] [Full Text] [Related]

  • 4. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.
    Immunol Lett; 2012 Dec 17; 148(2):117-25. PubMed ID: 23085605
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X.
    Int J Mol Med; 2012 Dec 17; 30(6):1335-42. PubMed ID: 23027427
    [Abstract] [Full Text] [Related]

  • 6. DNA vaccines against HPV-16 E7-expressing tumour cells.
    De Marco F, Hallez S, Brulet JM, Gesché F, Marzano P, Flamini S, Marcante ML, Venuti A.
    Anticancer Res; 2003 Dec 17; 23(2B):1449-54. PubMed ID: 12820408
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic synergy of human papillomavirus E7 subunit vaccines plus cisplatin in an animal tumor model: causal involvement of increased sensitivity of cisplatin-treated tumors to CTL-mediated killing in therapeutic synergy.
    Bae SH, Park YJ, Park JB, Choi YS, Kim MS, Sin JI.
    Clin Cancer Res; 2007 Jan 01; 13(1):341-9. PubMed ID: 17200373
    [Abstract] [Full Text] [Related]

  • 8. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B.
    Vaccine; 2012 Feb 01; 30(6):1071-82. PubMed ID: 22178528
    [Abstract] [Full Text] [Related]

  • 9. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA, Chang MC, Sun WZ, Chen YL, Chiang YC, Hsieh CY, Chen SM, Hsiao PN, Cheng WF.
    Gene Ther; 2009 Jun 01; 16(6):776-87. PubMed ID: 19357714
    [Abstract] [Full Text] [Related]

  • 10. Enhanced anti-tumor effects of HPV16E7(49-57)-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150.
    Chen S, Ou R, Tang J, Deng X, Wu Y, van Velkinburgh JC, Ni B, Xu Y.
    Cancer Epidemiol; 2013 Apr 01; 37(2):172-8. PubMed ID: 23127963
    [Abstract] [Full Text] [Related]

  • 11. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT, Yen CF, Shaw SW, Yen TC, Chen YJ, Soong YK, Lai CH.
    Vaccine; 2009 Dec 09; 27(52):7352-8. PubMed ID: 19781679
    [Abstract] [Full Text] [Related]

  • 12. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
    Chen CH, Ji H, Suh KW, Choti MA, Pardoll DM, Wu TC.
    Gene Ther; 1999 Dec 09; 6(12):1972-81. PubMed ID: 10637448
    [Abstract] [Full Text] [Related]

  • 13. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
    Meshkat Z, Soleimanjahi H, Mirshahabi H, Meshkat M, Kheirandish M, Hassan ZM.
    Iran J Immunol; 2011 Jun 09; 8(2):65-75. PubMed ID: 21705833
    [Abstract] [Full Text] [Related]

  • 14. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
    Yin R, Zheng W, Hao F, Yang XC, Zhong BY, Li QJ.
    J Dermatol Sci; 2009 Aug 09; 55(2):116-22. PubMed ID: 19500947
    [Abstract] [Full Text] [Related]

  • 15. The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA.
    Ohlschläger P, Spies E, Alvarez G, Quetting M, Groettrup M.
    Int J Cancer; 2011 Jan 15; 128(2):473-81. PubMed ID: 20309939
    [Abstract] [Full Text] [Related]

  • 16. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B, Ye D, Song X, Zhao X, Yi L, Song J, Zhang Z, Zhao Q.
    Vaccine; 2008 Mar 04; 26(10):1387-96. PubMed ID: 18272260
    [Abstract] [Full Text] [Related]

  • 17. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A, Zahedifard F, Taghikhani M, Rafati S.
    Vaccine; 2008 Jun 19; 26(26):3362-70. PubMed ID: 18471945
    [Abstract] [Full Text] [Related]

  • 18. A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers.
    Radaelli A, De Giuli Morghen C, Zanotto C, Pacchioni S, Bissa M, Franconi R, Massa S, Paolini F, Muller A, Venuti A.
    Virus Res; 2012 Dec 19; 170(1-2):44-52. PubMed ID: 22951311
    [Abstract] [Full Text] [Related]

  • 19. Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer.
    Jeon YH, Lee HW, Lee YL, Kim JE, Hwang MH, Jeong SY, Lee SW, Ahn BC, Ha JH, Lee J.
    Cancer Biother Radiopharm; 2011 Dec 19; 26(6):671-9. PubMed ID: 22091632
    [Abstract] [Full Text] [Related]

  • 20. Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.
    Tseng CW, Trimble C, Zeng Q, Monie A, Alvarez RD, Huh WK, Hoory T, Wang MC, Hung CF, Wu TC.
    Cancer Immunol Immunother; 2009 May 19; 58(5):737-48. PubMed ID: 18815785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.